Rachel K. King

2015

In 2015, Rachel K. King earned a total compensation of $1.4M as President and Chief Executive Officer at GlycoMimetics, a 52% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$195,368
Option Awards$717,690
Salary$459,690
Total$1,372,748

King received $717.7K in option awards, accounting for 52% of the total pay in 2015.

King also received $195.4K in non-equity incentive plan and $459.7K in salary.

Rankings

In 2015, Rachel K. King's compensation ranked 6,416th out of 13,638 executives tracked by ExecPay. In other words, King earned more than 53.0% of executives.

ClassificationRankingPercentile
All
6,416
out of 13,638
53rd
Division
Manufacturing
2,404
out of 5,190
54th
Major group
Chemicals And Allied Products
870
out of 1,854
53rd
Industry group
Drugs
695
out of 1,528
55th
Industry
Pharmaceutical Preparations
543
out of 1,182
54th
Source: SEC filing on April 20, 2017.

King's colleagues

We found three more compensation records of executives who worked with Rachel K. King at GlycoMimetics in 2015.

2015

Helen Thackray

GlycoMimetics

Chief Medical Officer

2015

John Magnani

GlycoMimetics

Chief Scientific Officer

2015

Brian Hahn

GlycoMimetics

Chief Financial Officer

News

In-depth

You may also like